Fernanda Ursoli Ferreira Melo

Fernanda Ursoli Ferreira Melo

Auto-generated profile, based on publicly available information

Fernanda Ursoli Ferreira Melo

National Institute of Science and Technology in Stem Cells and Cell Therapy, Ribeirão Preto, São Paulo, Brazil

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2011 in Experimental and Molecular Pathology
Verified
Journal Article
Closed access
ACAndrielle Castilho-Fernandes
Andrielle Castilho-Fernandes
DADanilo Candido Almeida
Danilo Candido Almeida
AFAparecida Maria Fontes
Aparecida Maria Fontes
FMFernanda Ursoli Ferreira Melo
Fernanda Ursoli Ferreira Melo
VPVirgínia Picanço-Castro
Virgínia Picanço-Castro
DCDimas Tadeu Covas
Dimas Tadeu Covas

1 March 2016 in Molecular & Cellular Proteomics
Verified
Journal Article
Open access
PDF file
CPCamila de Souza Palma
Camila de Souza Palma
MGMariana Lopes Grassi
Mariana Lopes Grassi
CTCarolina Hassibe Thomé
Carolina Hassibe Thomé
GFGermano Ferreira
Germano Ferreira
DADaniele Albuquerque
Daniele Albuquerque
VFVitor Marcel Faça
Vitor Marcel Faça
Epithelial to mesenchymal transition (EMT)1 occurs naturally during embryogenesis, tissue repair, cancer progression, and metastasis. EMT induces cellular and microenvironmental changes resulting in loss of epithelial and acquisition of mesenchymal phenotypes, which promotes cellular invasive and migratory capabilities. EMT can be triggered by extracellular factors, including TGF-β, HGF, and EGF. Overexpression of transcription factors, such as SNAIL, SLUG, ZEB1/2, and TWIST1, also induces EMT and is correlated to cancer aggressiveness. Here, the breast adenocarcinoma cell line MCF7 was transduced with SNAIL to identify specific mechanisms controlled by this transcription factor during EMT. Overexpression of SNAIL led to EMT, which was thoroughly validated by molecular, morphological, and functional experiments. Subcellular proteome enrichment followed by GEL-LC-MS/MS was performed to provide extensive protein fractionation and in-depth proteomic analysis. Quantitative analysis relied on a SILAC strategy, using the invasive breast cancer cell line MDA-MB-231 as a reference for quantitation. Subsets of proteins enriched in each subcellular compartment led to a complementary list of 4289 proteins identified with high confidence. A subset of differentially expressed proteins was validated by Western blot, including regulation in specific cellular compartments, potentially caused by protein translocation. Protein network analysis highlighted complexes involved in cell cycle control and epigenetic regulation. Flow cytometry analysis indicated that SNAIL overexpression led to cell cycle arrest in G0/G1 phases. Furthermore, down-regulation of HDAC1 was observed, supporting the involvement of epigenetic processes in SNAIL-induced EMT. When HDAC1 activity was inhibited, MCF7 not only apparently initiated EMT but also up-regulated SNAIL, indicating the cross-talk between these two proteins. Both HDAC1 inhibition and SNAIL overexpression activated the AKT pathway. These molecular mechanisms appear to be essential to EMT and therefore for cancer metastasis. Specific control of such epigenetic processes might then represent effective approaches for clinical management of metastatic cancer.

7 October 2017 in Angiogenesis
Verified
Journal Article
Closed access
PDF file
LSLucas E. B. Souza
Lucas E. B. Souza
LBLiziane R. Beckenkamp
Liziane R. Beckenkamp
LSLays M. Sobral
Lays M. Sobral
DFDaianne M. C. Fantacini
Daianne M. C. Fantacini
FMFernanda U. F. Melo
Fernanda U. F. Melo
DCDimas Tadeu Covas
Dimas Tadeu Covas